Idexx Laboratories Capitalized Contract Cost, Net decreased by 0.5% to $21.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.6%, from $22.80M to $21.30M. Over 5 years (FY 2020 to FY 2025), Capitalized Contract Cost, Net shows an upward trend with a 4.1% CAGR.
An increase suggests high investment in customer acquisition, while a decrease may indicate lower sales activity or changes in amortization schedules.
This represents the costs incurred to obtain or fulfill a contract that are capitalized and amortized over the expected...
Common in SaaS and service-based companies with high customer acquisition costs.
other_capitalized_contract_cost_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.40M | $19.00M | $19.50M | $19.40M | $19.30M | $19.00M | $19.20M | $19.30M | $19.50M | $19.20M | $19.70M | $19.70M | $19.60M | $20.60M | $22.00M | $22.80M | $21.50M | $21.50M | $21.40M | $21.30M |
| QoQ Change | — | +3.3% | +2.6% | -0.5% | -0.5% | -1.6% | +1.1% | +0.5% | +1.0% | -1.5% | +2.6% | +0.0% | -0.5% | +5.1% | +6.8% | +3.6% | -5.7% | +0.0% | -0.5% | -0.5% |
| YoY Change | — | — | — | — | +4.9% | +0.0% | -1.5% | -0.5% | +1.0% | +1.1% | +2.6% | +2.1% | +0.5% | +7.3% | +11.7% | +15.7% | +9.7% | +4.4% | -2.7% | -6.6% |